Gavin MacBeath
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-07-21–present
-
Current
2023-05-24–present
-
TScan Therapeutics, Inc. (TCRX)
SEC 8-K
Current2022-06-01–present
-
Current
2018-01-01–present
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | TScan Therapeutics, Inc. (TCRX) | Chief Executive Officer and Director | $665,000 | $2,801,450 |
| 2024 | TScan Therapeutics, Inc. (TCRX) | Chief Executive Officer and Director | $620,000 | $1,760,671 |
| 2023 | TScan Therapeutics, Inc. (TCRX) | Chief Executive Officer and Director | $545,121 | $3,196,054 |
| 2022 | TScan Therapeutics, Inc. (TCRX) | Chief Executive Officer and Director | $450,000 | $1,361,727 |
| 2021 | TScan Therapeutics, Inc. (TCRX) | Acting Chief Executive Officer, Chief Scientific and Operating Officer | $400,000 | $1,189,840 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.